Navigation Links
Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results
Date:1/28/2009

of $13.6 million.
  • Biomaterial product sales of $25.8 million, representing an increase of 19% from prior fiscal year period.
  • Orthopaedic royalties of $2.9 million, representing an increase of 33% from prior fiscal year period.
  • President and CEO Commentary

    "Our second quarter results demonstrated that our business fundamentals remain solid," said Joe Kaufmann, President and CEO of the Company. "For the second consecutive quarter, we have achieved record earnings and double digit increases in our biomaterial sales and orthopaedic royalties. Our balance sheet continued to strengthen by generating $4.7 million in operating cash flow in the quarter and $13.6 million through the first half of our fiscal year, and we currently expect our operating cash flow for the full fiscal year will be over $25 million. Our Angio-Seal royalties remained solid at $5.4 million despite the negative impact of foreign currency exchange of approximately $200,000. We have continued to make significant progress with both of our cartilage repair and extracellular matrix technology programs during the quarter and both programs remain on schedule. Additionally, our endovascular development programs have continued on schedule and we expect to achieve an additional milestone by the end of our fiscal year. Obviously, the current economic climate continues to be a concern and the deterioration of the Euro has adversely impacted our Angio-Seal royalties in the second quarter and our royalty expectations for the fiscal year."

    Second Quarter Results

    Revenues: Sales and Royalties. Total revenues increased 6% to $20.8 million in the Company's fiscal quarter ended December 31, 2008, from $19.6 million in the comparable prior fiscal year period.

    Net sales increased 6% to $14.0 million in the second quarter of fiscal 2009 from $13.1 million in the sec
    '/>"/>

    SOURCE Kensey Nash Corporation
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

    Related biology technology :

    1. Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
    2. Kensey Nash Corporation Announces Its Third Quarter 2008 Earnings Release Date and Teleconference
    3. Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
    4. Kensey Nash to Present at the Canaccord Adams Small-Cap Orthopedics Conference
    5. Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference
    6. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
    7. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
    8. Aerolase Reports Strong Sales in 2008 for Portable Aesthetic Lasers
    9. GEN Reports on Growing Reliance on Microfluidics Technology
    10. Novozymes Reports Strong 2008 Results
    11. International Robotic Urology Symposium Reports on Benefits of Cooling During Robotic-Assisted Prostate Surgery and Introduces InnerCools New Investigational UroCool System
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/1/2015)... 1, 2015 InferMed , ... will ... evidence-based clinical s olutions suite   ... information products and services, announced today the acquisition of  InferMed ... (CDS) technology company. InferMed,s Arezzo technology supports clinicians ...
    (Date:7/1/2015)...  UCB, a multinational biopharmaceutical company, and Genpact ... designing, transforming, and running intelligent business operations, have ... their close collaboration in driving transformation that achieved ... (GBS) finance organization. The Aecus Innovation ... together effectively to embrace the innovative promise of ...
    (Date:6/30/2015)... , June 30, 2015 /PRNewswire/ - Resverlogix ... of common shares of Resverlogix have approved the ... Eastern Capital Limited of 5,600,000 units at a ... Placement"), each unit being comprised of one common ... aggregate proceeds of approximately CAD$15 million; and (ii) ...
    (Date:6/30/2015)... June 30, 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: ... developing therapeutics that address unmet medical needs in ... Elston will present at the Cantor Fitzgerald ... 8, 2015Time: , 4:45 PM EDTLocation: , Le ... archive): , www.juniperpharma.com, under  ,Investor, or  ...
    Breaking Biology Technology:Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3Juniper Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 2
    ... July 1 Liko, a major supplier of,patient ... industry,has announced two new additions to its "Stat" ... Both new products, the Stat HandySheet(TM) and the ... patients or the movement of,patients in bed., ...
    ... (67%) of Americans are generally concerned about ... according to a 2008 National Consumer Water ... warning of contaminants1 (i.e. lead, radium, chlorine) ... controversy and confusion. Consumers are also learning ...
    ... July 1 Neogen Corporation,(Nasdaq: NEOG ) ... line used in,animal health and hygiene applications from ... 14 different product formulations,along with manufacturing process know-how ... were not disclosed., The addition of these ...
    Cached Biology Technology:Liko Introduces Two Additions to Its 'Stat' Family of Low Friction Sheets 2 Culligan's New Aqua-Cleer Advanced Drinking Water SystemProvides Clean, Quality Water Customized for Every Home 2 Culligan's New Aqua-Cleer Advanced Drinking Water SystemProvides Clean, Quality Water Customized for Every Home 3Neogen Acquires Product Line From DuPont Animal Health Solutions 2
    (Date:6/24/2015)... -- The biologics safety testing market is growing at ... include growth of the pharmaceutical and biological industries and ... years, the number of drug approvals in North American ... approved 225 drug applications and Health Canada approved 99. ... accounted for 3,822 of the pharmaceutical and 1,998 ...
    (Date:6/24/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/hhwlfj/huawei_ascend ... "Huawei Ascend Mate 7 Fingerprint Sensor - Reverse ... Huawei,s technological choice for the fingerprint sensor ... and Samsung,s one. The Ascend Mate 7 presents ... a main actor in capacitive sensing human interface ...
    (Date:6/23/2015)... 2015 Research and ... the "Body-Worn Temperature Sensors Market - Global ... 2014 - 2020" report to their offering. ... the global body-worn temperature sensors market. The global ... the basis of types, care setting, patient demographic, ...
    Breaking Biology News(10 mins):Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2Body-Worn Temperature Sensors Market - Global Industry Analysis 2
    ... USC have unlocked the mystery of why new cases of ... that causes the disease disproportionately increases a normal father,s production ... Noonan syndrome mutation arises in a normal sperm stem cell ... stem cells lacking the mutation. The father then is more ...
    ... , June 6, 2013 Research and ... the "DNA Microarray 2013: A Focus on Sales ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ,DNA Microarray 2013 presents the ... involving the participation of 201 buyers and end-users in ...
    ... a new field in medicine curing diseases by replacing ... artificial limb replaces the function of a leg or arm ... science on the cusp of chemistry and biology who focuses ... water. They will deliver the next talks in the ...
    Cached Biology News:DNA Microarray 2013 Market Report: A Focus on Sales Growth 2Medicine, energy topics of Kavli lectures at American Chemical Society meeting 2Medicine, energy topics of Kavli lectures at American Chemical Society meeting 3
    ...
    Pronase Reagent...
    CircuLex Anti-Human S100P Polyclonal Antibody Research Focus: proliferation Storage: -20C Shipping Temperature: 4C...
    Rabbit polyclonal to ECSIT ( Abpromise for all tested applications). entrezGeneID: 51295 SwissProtID: Q96HQ7...
    Biology Products: